Logista Pharma will be responsible for the distribution of the products of Unilever's new Pharmacy division - U-Labs - in Spain.
The mass consumer group Unilever, owner of brands such as Dove Rexona and Signal, has selected Logista Pharma to distribute the products of its new Pharmacy division (U-Labs) in Spain.
Unilever has valued Logista Pharma's extensive experience in the pharmaceutical channel, the breadth of its catalogue of distribution, administrative, financial and commercial services and the excellence of its services.
U-labs will begin operating in pharmacies through two oral health brands acquired in 2019 - Fluocaril and Parogencyl - two iconic brands in Spain, which are already highly recommended and have penetrated the Spanish market.
Fluocaril was launched in 1947 in France as the first fluoride-containing toothpaste, with unique bi-fluoride formulations and unique brand positioning to combat caries.
Parogencyl, a specialist gum care brand designed to address specific gum problems with a unique treatment and prevention regime.
The Unilever group is one of the world's leading consumer companies, producing and selling nearly 400 brands in more than 190 countries and employing more than 160,000 people. In 2019 the group had a turnover of 52.000 million euros, of which 538 million were in Spain.
Logista Pharma, a Logista company, is the Pharmaceutical Distributor specialized in Hospitals and Pharmacies, in Spain and Portugal, having the widest range of services to cover all the needs of pharmaceutical and Healthcare products. Logista Pharma currently works with more than 200 client laboratories.
Logista Pharma relies on the transport companies of Logista, Nacex, Integra2 and Logesta, for the distribution of pharmaceutical products, ensuring full operational integration, physical and thermal traceability in real time, with the highest quality standards and the use of state-of-the-art information systems.
Logista is the leading distributor of products and services to local businesses (kiosks, service stations, pharmacies, hospitals, tobacconists, etc.) in southern Europe, reaching around 250,000 points of sale in Spain, France, Italy and Portugal, thus facilitating the best and fastest access to the market for all types of products.